Divis Laboratories is currently trading at Rs. 1275.05, up by 84.75 points or 7.12% from its previous closing of Rs. 1190.30 on the BSE.
The scrip opened at Rs. 1200.00 and has touched a high and low of Rs. 1279.90 and Rs. 1200.00 respectively. So far 72,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1279.90 on 16-Aug-2016 and a 52 week low of Rs. 918.10 on 29-Feb-2016.
Last one week high and low of the scrip stood at Rs. 1279.90 and Rs. 1144.10 respectively. The current market cap of the company is Rs. 33,855.21 crore.
The promoters holding in the company stood at 52.08%, while Institutions and Non-Institutions held 33.94% and 13.98% respectively.
The company has registered growth of 23.10% in its net profit at Rs 301.81 crore for first quarter ended June 30, 2016 as compared to Rs 245.18 crore for the same quarter in the previous year. Total income of the company increased by 21.53% at Rs 1024.39 crore for quarter under review as compared to Rs 842.93 crore for the quarter ended June 30, 2015.
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry